Form 4: Avid Bioservices CEO Nicholas Green Sells Shares in Multiple Transactions

Avid Bioservices CEO Nicholas Green sold a total of 226,653 shares of common stock in multiple transactions between December 20th and December 24th, 2024.

Summary

• Nicholas Green, the President and CEO of Avid Bioservices, Inc., sold a total of 226,653 shares of the company's common stock.
• The sales occurred in three separate transactions between December 20th and December 24th, 2024.
• On December 20th, 75,000 shares were sold at a weighted average price of $12.3122 per share.
• On December 23rd, 100,000 shares were sold at a weighted average price of $12.2794 per share.
• On December 24th, the remaining 51,653 shares were sold at a weighted average price of $12.2746 per share.
• Following these transactions, Mr. Green no longer directly owns any shares of Avid Bioservices common stock.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the CEO selling a large number of shares, which can be interpreted as a lack of confidence in the company's future performance. This could lead to a decrease in investor confidence and potentially a drop in the stock price.

Negatives

• The CEO's sale of a significant number of shares could be interpreted negatively by the market.

Risks

• Insider selling can sometimes signal a lack of confidence in the company's future prospects, potentially impacting investor sentiment.
• Large sales by insiders can create downward pressure on the stock price.

Industry Context

This is a standard SEC Form 4 filing, which is required when company insiders trade shares. It is common for executives to sell shares for personal financial reasons, but the market often scrutinizes these transactions for potential implications.

Comparison to Industry Standards

• Insider sales are a common occurrence in publicly traded companies, and the frequency and volume of such sales can vary widely.
• It is typical for executives to have pre-arranged trading plans (like 10b5-1 plans) to avoid accusations of insider trading, but this document does not specify if these sales were part of such a plan.
• Comparing this to other CDMO companies, it is not unusual to see insider transactions, but the impact on the stock price depends on the size of the sale relative to the executive's holdings and the overall market sentiment.

Stakeholder Impact

• Shareholders may react negatively to the CEO's share sales, potentially leading to a decrease in the stock price.
• Employees may be concerned about the implications of the CEO's actions on the company's future.

Key Dates

Keywords

Avid Bioservices, Nicholas Green, stock sale, insider trading, CDMO, share transaction, executive sale